scRNA-Seq and flow cytometric analysis of PBMCs isolated from the patient before treatment showed PD-1 expression on malignant T cells (Figure 3, A and B), and this was validated by immunofluorescence staining of skin tumor samples (Figure 3C). The gene discussed is PDCD1; the disease is skin neoplasm.